Vitamin D metabolites in captivity? Should we measure free or total 25(OH)D to assess vitamin D status?

Journal of Steroid Biochemistry and Molecular Biology

Volumn 173, Issue , 2017, Pages 105-116

  Bikle, Daniel ^a   Bouillon, Roger ^b   Thadhani, Ravi ^c   Schoenmakers, Inez ^d,e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d MEDICAL RESEARCH COUNCIL   (United Kingdom)

^e UNIVERSITY OF EAST ANGLIA   (United Kingdom)

Author keywords

Centrifugal ultrafiltration; Free vitamin D metabolites; Genetic polymorphism; Keratinocytes; Liver disease; Pregnancy; Vitamin D binding protein

Indexed keywords

25 HYDROXYVITAMIN D; BIOLOGICAL MARKER; CALCITRIOL; CALCIUM; HORMONE; VITAMIN D; VITAMIN D BINDING PROTEIN; 25-HYDROXYVITAMIN D; PROTEIN BINDING; VITAMIN;

BONE METABOLISM; CALCIUM METABOLISM; CENTRIFUGAL ULTRAFILTRATION ASSAY; CLINICAL OUTCOME; ETHNIC DIFFERENCE; ETHNICITY; HORMONE DETERMINATION; HUMAN; IMMUNOASSAY; INTERMETHOD COMPARISON; LIVER DISEASE; METABOLITE; NONHUMAN; NORMAL HUMAN; PREGNANT WOMAN; RACE; REVIEW; VITAMIN METABOLISM; ANALOGS AND DERIVATIVES; ANIMAL; BLOOD; GENETIC POLYMORPHISM; GENETICS; METABOLISM; PROCEDURES; ULTRAFILTRATION; VITAMIN D DEFICIENCY;

ANIMALS; HUMANS; IMMUNOASSAY; POLYMORPHISM, GENETIC; PROTEIN BINDING; ULTRAFILTRATION; VITAMIN D; VITAMIN D DEFICIENCY; VITAMIN D-BINDING PROTEIN; VITAMINS;

EID: 85009781724     PISSN: 09600760     EISSN: 18791220     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2017.01.007     Document Type: Review

References (108)

1. Mendel, C.M., The free hormone hypothesis: a physiologically based mathematical model. Endocr. Rev. 10:3 (1989), 232–274.
2. Mendel, C.M., The free hormone hypothesis. Distinction from the free hormone transport hypothesis. J. Androl. 13:2 (1992), 107–116.
3. Vermeulen, A., Verdonck, L., Kaufman, J.M., A critical evaluation of simple methods for the estimation of free testosterone in serum. J. Clin. Endocrinol. Metab. 84:10 (1999), 3666–3672.
4. Bikle, D.D., Gee, E., Halloran, B., Kowalski, M.A., Ryzen, E., Haddad, J.G., Assessment of the free fraction of 25-hydroxyvitamin D in serum and its regulation by albumin and the vitamin D-binding protein. J. Clin. Endocrinol. Metab. 63:4 (1986), 954–959.
5. Bouillon, R., Vanassche, F.A., Vanbaelen, H., Heyns, W., Demoor, P., Influence of the vitamin D-binding protein on the serum concentration of 1,25-dihydroxyvitamin D3—significance of the free 1,25-dihydroxyvitamin D3 concentration. J. Clin. Invest. 67:3 (1981), 589–596.
6. Chun, R.F., Lauridsen, A.L., Suon, L., Zella, L.A., Pike, J.W., Modlin, R.L., Martineau, A.R., Wilkinson, R.J., Adams, J., Hewison, M., Vitamin D-binding protein directs monocyte responses to 25-hydroxy- and 1,25-dihydroxyvitamin D. J. Clin. Endocrinol. Metab. 95:7 (2010), 3368–3376.
7. Chun, R.F., Peercy, B.E., Adams, J.S., Hewison, M., Vitamin D binding protein and monocyte response to 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D: analysis by mathematical modeling. PLoS One, 7(1), 2012, e30773.
8. Zella, L.A., Shevde, N.K., Hollis, B.W., Cooke, N.E., Pike, J.W., Vitamin D-binding protein influences total circulating levels of 1,25-dihydroxyvitamin D3 but does not directly modulate the bioactive levels of the hormone in vivo. Endocrinology 149:7 (2008), 3656–3667.
9. Vargas, S., Bouillon, R., Van Baelen, H., Raisz, L.G., Effects of vitamin D-binding protein on bone resorption stimulated by 1,25 dihydroxyvitamin D3. Calcif. Tissue Int. 47:3 (1990), 164–168.
10. Safadi, F.F., Thornton, P., Magiera, H., Hollis, B.W., Gentile, M., Haddad, J.G., Liebhaber, S.A., Cooke, N.E., Osteopathy and resistance to vitamin D toxicity in mice null for vitamin D binding protein. J. Clin. Invest. 103:2 (1999), 239–251.
11. Orchinik, M., Hastings, N., Witt, D., McEwen, B.S., High-affinity binding of corticosterone to mammalian neuronal membranes: possible role of corticosteroid binding globulin. J. Steroid Biochem. Mol. Biol. 60:3–4 (1997), 229–236.
12. Hryb, D.J., Khan, M.S., Romas, N.A., Rosner, W., The control of the interaction of sex hormone-binding globulin with its receptor by steroid hormones. J. Biol. Chem. 265:11 (1990), 6048–6054.
13. Nykjaer, A., Dragun, D., Walther, D., Vorum, H., Jacobsen, C., Herz, J., Melsen, F., Christensen, E.I., Willnow, T.E., An endocytic pathway essential for renal uptake and activation of the steroid 25-(OH) vitamin D3. Cell 96:4 (1999), 507–515.
14. Schmidt-Gayk, H., Grawunder, C., Tschope, W., Schmitt, W., Ritz, E., Pietsch, V., Andrassy, K., Bouillon, R., 25-Hydroxy-vitamin-D in nephrotic syndrome. Lancet 2:8029 (1977), 105–108.
15. Christensen, E.I., Birn, H., Verroust, P., Moestrup, S.K., Megalin-mediated endocytosis in renal proximal tubule. Ren. Fail. 20:2 (1998), 191–199.
16. Marzolo, M.P., Farfan, P., New insights into the roles of megalin/LRP2 and the regulation of its functional expression. Biol. Res. 44:1 (2011), 89–105.
17. Braun, A., Bichlmaier, R., Cleve, H., Molecular analysis of the gene for the human vitamin-D-binding protein (group-specific component): allelic differences of the common genetic GC types. Hum. Genet. 89:4 (1992), 401–406.
18. Bouillon, R., Van Schoor, N.M., Gielen, E., Boonen, S., Mathieu, C., Vanderschueren, D., Lips, P., Optimal vitamin D status: a critical analysis on the basis of evidence-based medicine. J. Clin. Endocrinol. Metab. 98:8 (2013), E1283–1304.
19. Rosen, C.J., Adams, J.S., Bikle, D.D., Black, D.M., Demay, M.B., Manson, J.E., Murad, M.H., Kovacs, C.S., The nonskeletal effects of vitamin D: an Endocrine Society scientific statement. Endocr. Rev. 33:3 (2012), 456–492.
20. Powe, C.E., Evans, M.K., Wenger, J., Zonderman, A.B., Berg, A.H., Nalls, M., Tamez, H., Zhang, D., Bhan, I., Karumanchi, S.A., Powe, N.R., Thadhani, R., Vitamin D-binding protein and vitamin D status of black Americans and white Americans. N. Engl. J. Med. 369:21 (2013), 1991–2000.
21. Diaz, V.A., Mainous, A.G. 3rd, Carek, P.J., Wessell, A.M., Everett, C.J., The association of vitamin D deficiency and insufficiency with diabetic nephropathy: implications for health disparities. J. Am. Board Fam. Med. JABFM 22:5 (2009), 521–527.
22. Orwoll, E., Nielson, C.M., Marshall, L.M., Lambert, L., Holton, K.F., Hoffman, A.R., Barrett-Connor, E., Shikany, J.M., Dam, T., Cauley, J.A., Vitamin D deficiency in older men. J. Clin. Endocrinol. Metab. 94:4 (2009), 1214–1222.
23. Wolf, M., Shah, A., Gutierrez, O., Ankers, E., Monroy, M., Tamez, H., Steele, D., Chang, Y., Camargo, C.A. Jr., Tonelli, M., Thadhani, R., Vitamin D levels and early mortality among incident hemodialysis patients. Kidney Int. 72:8 (2007), 1004–1013.
24. Hannan, M.T., Litman, H.J., Araujo, A.B., McLennan, C.E., McLean, R.R., McKinlay, J.B., Chen, T.C., Holick, M.F., Serum 25-hydroxyvitamin D and bone mineral density in a racially and ethnically diverse group of men. J. Clin. Endocrinol. Metab. 93:1 (2008), 40–46.
25. Nielson, C.M., Jones, K.S., Bouillon, R., Osteoporotic Fractures in Men Research, G., Chun, R.F., Jacobs, J., Wang, Y., Hewison, M., Adams, J.S., Swanson, C.M., Lee, C.G., Vanderschueren, D., Pauwels, S., Prentice, A., Smith, R.D., Shi, T., Gao, Y., Zmuda, J.M., Lapidus, J., Cauley, J.A., Schoenmakers, I., Orwoll, E.S., Role of assay type in determining free 25-hydroxyvitamin D levels in diverse populations. N. Engl. J. Med. 374:17 (2016), 1695–1696.
26. Powe, C.E., Ricciardi, C., Berg, A.H., Erdenesanaa, D., Collerone, G., Ankers, E., Wenger, J., Karumanchi, S.A., Thadhani, R., Bhan, I., Vitamin D-binding protein modifies the vitamin D-bone mineral density relationship. J. Bone Miner. Res. 26:7 (2011), 1609–1616.
27. Bhan, I., Powe, C.E., Berg, A.H., Ankers, E., Wenger, J.B., Karumanchi, S.A., Thadhani, R.I., Bioavailable vitamin D is more tightly linked to mineral metabolism than total vitamin D in incident hemodialysis patients. Kidney Int. 82:1 (2012), 84–89.
28. Al-oanzi, Z.H., Tuck, S.P., Raj, N., Harrop, J.S., Summers, G.D., Cook, D.B., Francis, R.M., Datta, H.K., Assessment of vitamin D status in male osteoporosis. Clin. Chem. 52:2 (2006), 248–254.
29. Nissen, J., Rasmussen, L.B., Ravn-Haren, G., Andersen, E.W., Hansen, B., Andersen, R., Mejborn, H., Madsen, K.H., Vogel, U., Common variants in CYP2R1 and GC genes predict vitamin D concentrations in healthy Danish children and adults. PLoS One, 9(2), 2014, e89907.
30. Elkum, N., Alkayal, F., Noronha, F., Ali, M.M., Melhem, M., Al-Arouj, M., Bennakhi, A., Behbehani, K., Alsmadi, O., Abubaker, J., Vitamin D insufficiency in Arabs and South Asians positively associates with polymorphisms in GC and CYP2R1 genes. PLoS One, 9(11), 2014, e113102.
31. Nissen, J., Vogel, U., Ravn-Haren, G., Andersen, E.W., Madsen, K.H., Nexo, B.A., Andersen, R., Mejborn, H., Bjerrum, P.J., Rasmussen, L.B., Wulf, H.C., Common variants in CYP2R1 and GC genes are both determinants of serum 25-hydroxyvitamin D concentrations after UVB irradiation and after consumption of vitamin D(3)-fortified bread and milk during winter in Denmark. Am. J. Clin. Nutr. 101:1 (2014), 218–227.
32. Ahn, J., Yu, K., Stolzenberg-Solomon, R., Simon, K.C., McCullough, M.L., Gallicchio, L., Jacobs, E.J., Ascherio, A., Helzlsouer, K., Jacobs, K.B., Li, Q., Weinstein, S.J., Purdue, M., Virtamo, J., Horst, R., Wheeler, W., Chanock, S., Hunter, D.J., Hayes, R.B., Kraft, P., Albanes, D., Genome-wide association study of circulating vitamin D levels. Hum. Mol. Genet. 19:13 (2010), 2739–2745.
33. Park, Y., Kim, Y.S., Kang, Y.A., Shin, J.H., Oh, Y.M., Seo, J.B., Jung, J.Y., Lee, S.D., Relationship between vitamin D-binding protein polymorphisms and blood vitamin D level in Korean patients with COPD. Int. J. Chronic Obstr. Pulm. Dis. 11 (2016), 731–738.
34. Braithwaite, V.S., Jones, K.S., Schoenmakers, I., Silver, M., Prentice, A., Hennig, B.J., Vitamin D binding protein genotype is associated with plasma 25OHD concentration in West African children. Bone 74 (2015), 166–170.
35. Sinotte, M., Diorio, C., Berube, S., Pollak, M., Brisson, J., Genetic polymorphisms of the vitamin D binding protein and plasma concentrations of 25-hydroxyvitamin D in premenopausal women. Am. J. Clin. Nutr. 89:2 (2009), 634–640.
36. Lauridsen, A.L., Vestergaard, P., Hermann, A.P., Brot, C., Heickendorff, L., Mosekilde, L., Nexo, E., Plasma concentrations of 25-hydroxy-vitamin D and 1,25-dihydroxy-vitamin D are related to the phenotype of Gc (vitamin D-binding protein): a cross-sectional study on 595 early postmenopausal women. Calcif. Tissue Int. 77:1 (2005), 15–22.
37. Al-oanzi, Z.H., Tuck, S.P., Mastana, S.S., Summers, G.D., Cook, D.B., Francis, R.M., Datta, H.K., Vitamin D-binding protein gene microsatellite polymorphism influences BMD and risk of fractures in men. Osteoporos. Int. 19:7 (2008), 951–960.
38. Wang, T.J., Zhang, F., Richards, J.B., Kestenbaum, B., van Meurs, J.B., Berry, D., Kiel, D.P., Streeten, E.A., Ohlsson, C., Koller, D.L., Peltonen, L., Cooper, J.D., O'Reilly, P.F., Houston, D.K., Glazer, N.L., Vandenput, L., Peacock, M., Shi, J., Rivadeneira, F., McCarthy, M.I., Anneli, P., de Boer, I.H., Mangino, M., Kato, B., Smyth, D.J., Booth, S.L., Jacques, P.F., Burke, G.L., Goodarzi, M., Cheung, C.L., Wolf, M., Rice, K., Goltzman, D., Hidiroglou, N., Ladouceur, M., Wareham, N.J., Hocking, L.J., Hart, D., Arden, N.K., Cooper, C., Malik, S., Fraser, W.D., Hartikainen, A.L., Zhai, G.J., Macdonald, H.M., Forouhi, N.G., Loos, R.J.F., Reid, D.M., Hakim, A., Dennison, E., Liu, Y.M., Power, C., Stevens, H.E., Jaana, L., Vasan, R.S., Soranzo, N., Bojunga, J., Psaty, B.M., Lorentzon, M., Foroud, T., Harris, T.B., Hofman, A., Jonsson, J.O., Cauley, J.A., Uitterlinden, A.G., Gibson, Q., Jarvelin, M.R., Karasik, D., Siscovick, D.S., Econs, M.J., Kritchevsky, S.B., Florez, J.C., Todd, J.A., Dupuis, J., Hypponen, E., Spector, T.D., Common genetic determinants of vitamin D insufficiency: a genome-wide association study. Lancet 376:9736 (2010), 180–188.
39. Papiha, S.S., Allcroft, L.C., Kanan, R.M., Francis, R.M., Datta, H.K., Vitamin D binding protein gene in male osteoporosis: association of plasma DBP and bone mineral density with (TAAA)(n)-Alu polymorphism in DBP. Calcif. Tissue Int. 65:4 (1999), 262–266.
40. Fang, Y., van Meurs, J.B.J., Arp, P., van Leeuwen, J.P.T., Hofman, A., Pols, H.A.P., Uitterlinden AG 2009 vitamin D binding protein genotype and osteoporosis. Calcif. Tissue Int. 85:2 (2016), 85–93.
41. Anderson, L.N., Cotterchio, M., Cole, D.E., Knight, J.A., Vitamin D-related genetic variants, interactions with vitamin D exposure, and breast cancer risk among Caucasian women in Ontario. Cancer Epidemiol. Biomark. Prev. 20:8 (2011), 1708–1717.
42. Carter, G.D., Phinney, K.W., Assessing vitamin D status: time for a rethink. Clin. Chem. 60:6 (2014), 809–811.
43. Arnaud, J., Constans, J., Affinity differences for vitamin D metabolites associated with the genetic isoforms of the human serum carrier protein (DBP). Hum. Genet. 92:2 (1993), 183–188.
44. Bouillon, R., van Baelen, H., de Moor, P., Comparative study of the affinity of the serum vitamin D-binding protein. J. Steroid Biochem. 13:9 (1980), 1029–1034.
45. Boutin, B., Galbraith, R.M., Arnaud, P., Comparative affinity of the major genetic variants of human group-specific component (vitamin D-binding protein) for 25-(OH) vitamin D. J. Steroid Biochem. 32:1A (1989), 59–63.
46. Bikle, D.D., Genant, H.K., Cann, C., Recker, R.R., Halloran, B.P., Strewler, G.J., Bone disease in alcohol abuse. Ann. Intern. Med. 103:1 (1985), 42–48.
47. Guarino, M., Loperto, I., Camera, S., Cossiga, V., Di Somma, C., Colao, A., Caporaso, N., Morisco, F., Osteoporosis across chronic liver disease. Osteoporos. Int. 27:6 (2016), 1967–1977.
48. Herlong, H.F., Recker, R.R., Maddrey, W.C., Bone disease in primary biliary cirrhosis: histologic features and response to 25-hydroxyvitamin D. Gastroenterology 83:1 Pt 1 (1982), 103–108.
49. Matloff, D.S., Kaplan, M.M., Neer, R.M., Goldberg, M.J., Bitman, W., Wolfe, H.J., Osteoporosis in primary biliary cirrhosis: effects of 25-hydroxyvitamin D3 treatment. Gastroenterology 83:1 Pt 1 (1982), 97–102.
50. Heaney, R.P., Skillman, T.G., Calcium metabolism in normal human pregnancy. J. Clin. Endocrinol. Metab. 33:4 (1971), 661–670.
51. Bikle, D.D., Gee, E., Halloran, B., Haddad, J.G., Free 1,25-dihydroxyvitamin D levels in serum from normal subjects, pregnant subjects, and subjects with liver disease. J. Clin. Invest. 74:6 (1984), 1966–1971.
52. Hammond, G.L., Nisker, J.A., Jones, L.A., Siiteri, P.K., Estimation of the percentage of free steroid in undiluted serum by centrifugal ultrafiltration-dialysis. J. Biol. Chem. 255:11 (1980), 5023–5026.
53. Bikle, D.D., Siiteri, P.K., Ryzen, E., Haddad, J.G., Serum protein binding of 1,25-dihydroxyvitamin D: a reevaluation by direct measurement of free metabolite levels. J. Clin. Endocrinol. Metab. 61:5 (1985), 969–975.
54. Nielson, C.M., Jones, K.S., Chun, R.F., Jacobs, J.M., Wang, Y., Hewison, M., Adams, J.S., Swanson, C.M., Lee, C.G., Vanderschueren, D., Pauwels, S., Prentice, A., Smith, R.D., Shi, T., Gao, Y., Schepmoes, A.A., Zmuda, J.M., Lapidus, J., Cauley, J.A., Bouillon, R., Schoenmakers, I., Orwoll, E.S., Osteoporotic Fractures in Men Research, G., Free 25-hydroxyvitamin D: impact of vitamin D binding protein assays on Racial-Genotypic Associations. J. Clin. Endocrinol. Metab. 101:5 (2016), 2226–2234.
55. Chun, R.F., Peercy, B.E., Orwoll, E.S., Nielson, C.M., Adams, J.S., Hewison, M., Vitamin D and DBP: the free hormone hypothesis revisited. J. Steroid Biochem. Mol. Biol. 144:Pt A (2014), 132–137.
56. Bikle, D.D., Halloran, B.P., Gee, E., Ryzen, E., Haddad, J.G., Free 25-hydroxyvitamin D levels are normal in subjects with liver disease and reduced total 25-hydroxyvitamin D levels. J. Clin. Invest. 78:3 (1986), 748–752.
57. Schwartz, J.B., Lai, J., Lizaola, B., Kane, L., Markova, S., Weyland, P., Terrault, N.A., Stotland, N., Bikle, D., A comparison of measured and calculated free 25(OH) vitamin D levels in clinical populations. J. Clin. Endocrinol. Metab. 99:5 (2014), 1631–1637.
58. Bikle, D.D., Gee, E., Free, and not total, 1,25-dihydroxyvitamin D regulates 25-hydroxyvitamin D metabolism by keratinocytes. Endocrinology 124:2 (1989), 649–654.
59. Bikle, D.D., Nemanic, M.K., Gee, E., Elias, P., 1,25-Dihydroxyvitamin D3 production by human keratinocytes. Kinetics and regulation. J. Clin. Invest. 78:2 (1986), 557–566.
60. Bikle, D.D., Nemanic, M.K., Whitney, J.O., Elias, P.W., Neonatal human foreskin keratinocytes produce 1,25-dihydroxyvitamin D3. Biochemistry 25:7 (1986), 1545–1548.
61. Olmos-Ortiz, A., Avila, E., Durand-Carbajal, M., Diaz, L., Regulation of calcitriol biosynthesis and activity: focus on gestational vitamin D deficiency and adverse pregnancy outcomes. Nutrients 7:1 (2015), 443–480.
62. Kane, L., Moore, K., Lutjohann, D., Bikle, D., Schwartz, J.B., Vitamin D3 effects on lipids differ in statin and non-statin-treated humans: superiority of free 25-OH D levels in detecting relationships. J. Clin. Endocrinol. Metab. 98:11 (2013), 4400–4409.
63. Lai, J.C., Bikle, D.D., Lizaola, B., Hayssen, H., Terrault, N.A., Schwartz, J.B., Total 25(OH) vitamin D, free 25(OH) vitamin D and markers of bone turnover in cirrhotics with and without synthetic dysfunction. Liver Int. 35:10 (2015), 2294–2300.
64. Schwartz, J.B., Kane, L., Bikle, D., Response of vitamin D concentration to vitamin D3 administration in older adults without sun exposure: a randomized double-blind trial. J. Am. Geriatr. Soc. 64:1 (2016), 65–72.
65. Denburg, M.R., Tsampalieros, A.K., de Boer, I.H., Shults, J., Kalkwarf, H.J., Zemel, B.S., Foerster, D., Stokes, D., Leonard, M.B., Mineral metabolism and cortical volumetric bone mineral density in childhood chronic kidney disease. J. Clin. Endocrinol. Metab. 98:5 (2013), 1930–1938.
66. Jones, K., Assar, S., Harnpanich, D., Bouillon, R., Lambrechts, D., Prentice, A., Schoenmakers, I., 25 (OH) D2 half-life is shorter than 25 (OH) D3 half-life and is influenced by DBP concentration and genotype. J. Clin. Endocrinol. Metab. 99:9 (2014), 3373–3381.
67. Aloia, J., Dhaliwal, R., Mikhail, M., Shieh, A., Stolberg, A., Ragolia, L., Fazzari, M., Abrams, S.A., Free 25(OH)D and calcium absorption, PTH, and markers of bone turnover. J. Clin. Endocrinol. Metab. 100:11 (2015), 4140–4145.
68. Jemielita, T., Leonard, M., Baker, J., Sayed, S., Zemel, B., Shults, J., Herskovitz, R., Denburg, M., Association of 25-hydroxyvitamin D with areal and volumetric measures of bone mineral density and parathyroid hormone: impact of vitamin D-binding protein and its assays. Osteoporos. Int., 2015, 1–10.
69. Denburg, M.R., Hoofnagle, A.N., Sayed, S., Gupta, J., de Boer, I.H., Appel, L.J., Durazo-Arvizu, R., Whitehead, K., Feldman, H.I., Leonard, M.B., Chronic Renal Insufficiency Cohort Study Investigators, Comparison of two ELISA methods and mass spectrometry for measurement of vitamin D-binding protein: implications for the assessment of bioavailable vitamin D concentrations across genotypes. J. Bone Miner. Res. 31:6 (2016), 1128–1136.
70. Henderson, C.M., Lutsey, P.L., Misialek, J.R., Laha, T.J., Selvin, E., Eckfeldt, J.H., Hoofnagle, A.N., Measurement by a novel LC-MS/MS methodology reveals similar serum concentrations of vitamin D-binding protein in blacks and whites. Clin. Chem. 62:1 (2016), 179–187.
71. Hoofnagle, A.N., Eckfeldt, J.H., Lutsey, P.L., Vitamin D–binding protein concentrations quantified by mass spectrometry. N. Engl. J. Med. 373:15 (2015), 1480–1482.
72. Alzaman, N.S., Dawson-Hughes, B., Nelson, J., D'Alessio, D., Pittas, A.G., Vitamin D status of black and white Americans and changes in vitamin D metabolites after varied doses of vitamin D supplementation. Am. J. Clin. Nutr. 104:1 (2016), 205–214.
73. Aloia, J., Mikhail, M., Dhaliwal, R., Shieh, A., Usera, G., Stolberg, A., Ragolia, L., Islam, S., Free 25 (OH) D and the vitamin D paradox in African Americans. J. Clin. Endocrinol. Metab. 100:9 (2015), 3356–3363.
74. Cauley, J.A., Chalhoub, D., Kassem, A.M., Fuleihan Gel, H., Geographic and ethnic disparities in osteoporotic fractures. Nat. Rev. Endocrinol. 10:6 (2014), 338–351.
75. Redmond, J., Jarjou, L.M., Zhou, B., Prentice, A., Schoenmakers, I., Ethnic differences in calcium, phosphate and bone metabolism. Proc. Nutr. Soc. 73:2 (2014), 340–351.
76. Yan, L., Schoenmakers, I., Zhou, B., Jarjou, L.M.A., Smith, E., Nigdikar, S., Goldberg, G.R., Prentice, A., Ethnic differences in parathyroid hormone secretion and mineral metabolism in response to oral phosphate administration. Bone 45:2 (2009), 238–245.
77. Aloia, J., Dhaliwal, R., Mikhail, M., Shieh, A., Stolberg, A., Ragolia, L., Fazzari, M., Abrams, S.A., Free 25 (OH) D and calcium absorption, PTH, and markers of bone turnover. J. Clin. Endocrinol. Metab. 100:11 (2015), 4140–4145.
78. Redmond, J., Palla, L., Yan, L., Jarjou, L.M., Prentice, A., Schoenmakers, I., Ethnic differences in urinary calcium and phosphate excretion between Gambian and British older adults. Osteoporos. Int. 26:3 (2015), 1125–1135.
79. Binkley, N., Sempos, C.T., Vitamin D Standardization Program (VDSP), Standardizing vitamin D assays: the way forward. J. Bone Miner. Res. 29:8 (2014), 1709–1714.
80. Faix, J.D., Principles and pitfalls of free hormone measurements. Best Pract. Res. Clin. Endocrinol. Metab. 27:5 (2013), 631–645.
81. Dastani, Z., Berger, C., Langsetmo, L., Fu, L., Wong, B.Y., Malik, S., Goltzman, D., Cole, D.E., Richards, J.B., In healthy adults, biological activity of vitamin D, as assessed by serum PTH, is largely independent of DBP concentrations. J. Bone Miner. Res. 29:2 (2014), 494–499.
82. Johnsen, M.S., Grimnes, G., Figenschau, Y., Torjesen, P.A., Almås, B., Jorde, R., Serum free and bio-available 25-hydroxyvitamin D correlate better with bone density than serum total 25-hydroxyvitamin D. Scand. J. Clin. Lab. Invest. 74:3 (2014), 177–183.
83. Pop, L.C., Shapses, S.A., Chang, B., Sun, W., Wang, X., Vitamin D-binding protein in healthy pre-and postmenopausal women: relationship with estradiol concentrations. Endocr. Pract. 21:8 (2015), 936–942.
84. Goswami, R., Saha, S., Sreenivas, V., et al. Vitamin D-binding protein, vitamin D status and serum bioavailable 25(OH)D of young Asian Indian males working in outdoor and indoor environments. J. Bone Miner. Metab., 2016, 10.1007/s00774-016-0739-x.
85. Shieh, A., Chun, R.F., Ma, C., Witzel, S., Meyer, B., Rafison, B., Swinkels, L., Huijs, T., Pepkowitz, S., Holmquist, B., Hewison, M., Adams, J.S., Effects of high-dose vitamin D2 versus vitamin D3 on total and free 25-hydroxyvitamin D and markers of calcium balance. J. Clin. Endocrinol. Metab. 101:8 (2016), 3070–3078.
86. Sollid, S.T., Hutchinson, M.Y.S., Berg, V., Fuskevåg, O.M., Figenschau, Y., Thorsby, P.M., Jorde, R., Effects of vitamin D binding protein phenotypes and vitamin D supplementation on serum total 25 (OH) D and directly measured free 25 (OH) D. Eur. J. Endocrinol., 2016 EJE-15-1089.
87. Reid, D., Toole, B.J., Knox, S., Talwar, D., Harten, J., O'Reilly, D.S.J., Blackwell, S., Kinsella, J., McMillan, D.C., Wallace, A.M., The relation between acute changes in the systemic inflammatory response and plasma 25-hydroxyvitamin D concentrations after elective knee arthroplasty. Am. J. Clin. Nutr. 93:5 (2011), 1006–1011.
88. Briggs, A.D., Kuan, V., Greiller, C.L., MacLaughlin, B.D., Ramachandran, M., Harris, T., Timms, P.M., Venton, T.R., Vieth, R., Norman, A.W., Longitudinal study of vitamin D metabolites after long bone fracture. J. Bone Miner. Res. 28:6 (2013), 1301–1307.
89. Aggarwal, A., Yadav, A.K., Ramachandran, R., Kumar, V., Kumar, V., Sachdeva, N., Khandelwal, N., Jha, V., Bioavailable vitamin D levels are reduced and correlate with bone mineral density and markers of mineral metabolism in adults with nephrotic syndrome. Nephrology (Carlton) 21:6 (2016), 483–489.
90. Denburg, M.R., Kalkwarf, H.J., de Boer, I.H., Hewison, M., Shults, J., Zemel, B.S., Stokes, D., Foerster, D., Laskin, B., Ramirez, A., Vitamin D bioavailability and catabolism in pediatric chronic kidney disease. Pediatr. Nephrol. 28:9 (2013), 1843–1853.
91. Lai, J.C., Bikle, D.D., Lizaola, B., Hayssen, H., Terrault, N.A., Schwartz, J.B., Total 25 (OH) vitamin D, free 25 (OH) vitamin D and markers of bone turnover in cirrhotics with and without synthetic dysfunction. Liver Int. 35:10 (2015), 2294–2300.
92. Anic, G.M., Weinstein, S.J., Mondul, A.M., Männistö, S., Albanes, D., Serum vitamin D, vitamin D binding protein, and risk of colorectal cancer. PLoS One, 9(7), 2014.
93. Anic, G.M., Weinstein, S.J., Mondul, A.M., Mannisto, S., Albanes, D., Serum vitamin D, vitamin D binding protein, and lung cancer survival. Lung Cancer 86:3 (2014), 297–303.
94. Mondul, A., Weinstein, S., Virtamo, J., Albanes, D., Influence of vitamin D binding protein on the association between circulating vitamin D and risk of bladder cancer. Br. J. Cancer 107:9 (2012), 1589–1594.
95. Weinstein, S.J., Stolzenberg-Solomon, R.Z., Kopp, W., Rager, H., Virtamo, J., Albanes, D., Impact of circulating vitamin D binding protein levels on the association between 25-hydroxyvitamin D and pancreatic cancer risk: a nested case-control study. Cancer Res. 72:5 (2012), 1190–1198.
96. Mondul, A.M., Weinstein, S.J., Moy, K.A., Männistö, S., Albanes, D., Vitamin D-binding protein, circulating vitamin D and risk of renal cell carcinoma. Int. J. Cancer 134:11 (2014), 2699–2706.
97. Ying, H.-Q., Sun, H.-L., He, B.-S., Pan, Y.-Q., Wang, F., Deng, Q.-W., Chen, J., Liu, X., Wang, S.-K., Circulating vitamin D binding protein, total, free and bioavailable 25-hydroxyvitamin D and risk of colorectal cancer. Sci. Rep., 5, 2015.
98. Weinstein, S.J., Purdue, M.P., Smith‐Warner, S.A., Mondul, A.M., Black, A., Ahn, J., Huang, W.Y., Horst, R.L., Kopp, W., Rager, H., Serum 25-hydroxyvitamin D, vitamin D binding protein and risk of colorectal cancer in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. Int. J. Cancer 136:6 (2015), E654–E664.
99. Wang, J., Eliassen, A.H., Spiegelman, D., Willett, W.C., Hankinson, S.E., Plasma free 25-hydroxyvitamin D, vitamin D binding protein, and risk of breast cancer in the Nurses’ Health Study II. Cancer Causes Control 25:7 (2014), 819–827.
100. Behrens, J.R., Rasche, L., Gieß, R.M., Pfuhl, C., Wakonig, K., Freitag, E., Deuschle, K., Bellmann-Strobl, J., Paul, F., Ruprecht, K., Low 25-hydroxyvitamin D, but not the bioavailable fraction of 25-hydroxyvitamin D, is a risk factor for multiple sclerosis. Eur. J. Neurol. 23:1 (2016), 62–67.
101. Ashraf, A.P., Huisingh, C., Alvarez, J.A., Wang, X., Gower, B.A., Insulin resistance indices are inversely associated with vitamin D binding protein concentrations. J. Clin. Endocrinol. Metab. 99:1 (2013), 178–183.
102. Ashraf, A.P., Alvarez, J.A., Dudenbostel, T., Calhoun, D., Griffin, R., Wang, X., Hanks, L.J., Gower, B.A., Associations between vascular health indices and serum total, free and bioavailable 25-hydroxyvitamin D in adolescents. PLoS One, 9(12), 2014, e114689.
103. Berg, I., Hanson, C., Sayles, H., Romberger, D., Nelson, A., Meza, J., Miller, B., Wouters, E.F., MacNee, W., Rutten, E., Vitamin D, vitamin D binding protein, lung function and structure in COPD. Respir. Med. 107:10 (2013), 1578–1588.
104. Leaf, D.E., Waikar, S.S., Wolf, M., Cremers, S., Bhan, I., Stern, L., Dysregulated mineral metabolism in patients with acute kidney injury and risk of adverse outcomes. Clin. Endocrinol. 79:4 (2013), 491–498.
105. Srikanth, P., Chun, R., Hewison, M., Adams, J., Bouillon, R., Vanderschueren, D., Lane, N., Cawthon, P., Dam, T., Barrett-Connor, E., Associations of total and free 25OHD and 1, 25 (OH) 2D with serum markers of inflammation in older men. Osteoporos. Int., 2016, 1–10.
106. Rebholz, C.M., Grams, M.E., Lutsey, P.L., Hoofnagle, A.N., Misialek, J.R., Inker, L.A., Levey, A.S., Selvin, E., Hsu C-y Kimmel, P.L., Biomarkers of vitamin D status and risk of ESRD. Am. J. Kidney Dis. 67:2 (2016), 235–242.
107. Kane, L., Moore, K., Lütjohann, D., Bikle, D., Schwartz, J.B., Vitamin D3 effects on lipids differ in statin and non-statin-treated humans: superiority of free 25-OH D levels in detecting relationships. J. Clin. Endocrinol. Metab. 98:11 (2013), 4400–4409.
108. Kawakami, M., Imawari, M., Goodman, D.S., Quantitative studies of the interaction of cholecalciferol ((vitamin D3) and its metabolites with different genetic variants of the serum binding protein for these sterols. Biochem. J. 179:2 (1979), 413–423.